Metalloproteinases and their inhibitors: the importance of extracellular matrix degradation in malignancy
Sela, B.
Harefuah 139(11-12): 446-451
2000
ISSN/ISBN: 0017-7768 PMID: 11341192 Document Number: 515145
Document emailed within 1 workday
Related Documents
Ylisirniö, S.; Höyhtyä, M.; Turpeenniemi-Hujanen, T. 2000: Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker Anticancer Research 20(2b): 1311-1316Akiyama, K.; Shikata, K.; Sugimoto, H.; Matsuda, M.; Shikata, Y.; Fujimoto, N.; Obata, K.; Matsui, H.; Makino, H. 1997: Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis Research Communications in Molecular Pathology and Pharmacology 95(2): 115-128
Yoshihara, Y.; Yamada, H. 2007: Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis Clinical Calcium 17(4): 500-508
McKerrow, J.H.; Keene, W.E.; Jeong, K.H.; Werb, Z. 1983: Degradation of extracellular matrix by larvae of Schistosoma mansoni. I. Degradation by cercariae as a model for initial parasite invasion of host Laboratory Investigation; A Journal of Technical Methods and Pathology 49(2): 195-200
Wang, D.; Zhang, L.; Li, F.; Xu, S.; Chen, J. 2014: Study of the types of matrix metalloproteinases involved in dentin bonding interface degradation Hua Xi Kou Qiang Yi Xue Za Zhi 32(4): 394-399
Morell-Quadreny, L.; Rubio, J.; Lopez-Guerrero, J.A.; Casanova, J.; Ramos, D.; Iborra, I.; Solsona, E.; Llombart-Bosch, A. 2003: Disruption of basement membrane, extracellular matrix metalloproteinases and E-cadherin in renal-cell carcinoma Anticancer Research 23(6d): 5005-5010
Woessner, J.F. 1992: Literature on vertebrate matrix metalloproteinases and their tissue inhibitors Matrix (Stuttgart, Germany). Supplement 1: 425-501
Andrade, Z.A. 1994: Extracellular matrix degradation in parasitic diseases Brazilian Journal of Medical and Biological Research 27(9): 2273-2281
Wasilewska, A.; Taranta-Janusz, K.; Zoch-Zwierz, W.; Rybi-Szumińska, A.; Kołodziejczyk, Z. 2009: Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology Przeglad Lekarski 66(9): 485-490
Ab Hamid, J.; Mohtarrudin, N.; Osman, M.; Andi Asri, A.A.; Wan Hassan, W.H.; Aziz, R. 2012: Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 and 2 as potential biomarkers for gestational hypertension Singapore Medical Journal 53(10): 681-683
Martin, J.; Yung, S.; Robson, R.L.; Steadman, R.; Davies, M. 2000: Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(5): 524-533
Morris-Wiman, J.; Du, Y.; Brinkley, L. 1999: Occurrence and temporal variation in matrix metalloproteinases and their inhibitors during murine secondary palatal morphogenesis Journal of Craniofacial Genetics and Developmental Biology 19(4): 201-212
Briozzo, P.; Morisset, M.; Capony, F.; Rougeot, C.; Rochefort, H. 1988: In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells Cancer Research 48(13): 3688-3692
Allen, L.E.; Dubeau, L.; Alvarez, O.; Jones, P.A. 1990: Rapid degradation of extracellular matrix proteins by normal human uroepithelial cells Cancer Research 50(6): 1897-1904
Woynarowska, B.; Wikiel, H.; Bernacki, R.J. 1989: Human ovarian carcinoma beta-N-acetylglucosaminidase isoenzymes and their role in extracellular matrix degradation Cancer Research 49(20): 5598-5604
Tsai, H.-C.; Ye, S.-Y.; Kunin, C.M.; Lee, S.S.-J.; Wann, S.-R.; Tai, M.-H.; Shi, M.-H.; Liu, Y.-C.; Chen, Y.-S. 2011: Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with HIV-1 infection and syphilis or neurosyphilis Cytokine 54(2): 109-116
Lindblad, W.J.; Fuller, G.C. 1982: An improved assay of mammalian collagenase activity, and its use to determine hepatic extracellular matrix susceptibility to degradation Clinical Chemistry 28(10): 2134-2138
Wei, Q.-X.; Wan, Y.-G.; Zhao, Q.; Chen, H.-L.; Meng, X.-J.; Yao, J. 2013: Molecular mechanisms of renal extracellular matrix degradation and interventional effects of Chinese herbal medicine Zhongguo Zhong Yao Za Zhi 38(4): 533-538
Gress, T.M.; Müller-Pillasch, F.; Lerch, M.M.; Friess, H.; Büchler, M.; Beger, H.G.; Adler, G. 1994: Balance of expression of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in chronic pancreatitis Zeitschrift für Gastroenterologie 32(4): 221-225
Delektorskaia, V.V.; Smirnova, E.A.; Ponomareva, M.V.; Pavlova, T.V.; Pavlov, I.A. 2010: Expression of matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in papillary thyroid cancer: an association with the clinical, morphological and ultrastructural characteristics of a tumor Arkhiv Patologii 72(4): 3-6